Vanguard Asset Management
COLL icon

Vanguard Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Vanguard Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$920K Buy
25,426
+5,534
+28% +$189K ﹤0.01% 1922
2026
Q1 		$658K Buy
+19,892
New +$842K ﹤0.01% 1970

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Asset Management's COLL Position: Q2 2026 in Review

Vanguard Asset Management increased its Collegium Pharmaceutical (COLL) stake by 28% in Q2 2026, buying an estimated $189K and bringing the position to 25,426 shares worth $920K. The position accounts for ﹤0.01% of the portfolio, ranked #1922.

Vanguard Asset Management first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. 257 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Vanguard Asset Management held 25,426 shares of Collegium Pharmaceutical worth $920K as of Q2 2026.
  • Vanguard Asset Management bought 5,534 Collegium Pharmaceutical shares in Q2 2026, an estimated $189K.
  • Collegium Pharmaceutical made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1922 holding.
  • Vanguard Asset Management first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 257 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.